Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is ten... Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.4715 | 9.22700587084 | 5.11 | 5.644 | 5.065 | 2881697 | 5.3519622 | CS |
| 4 | 0.0815 | 1.48181818182 | 5.5 | 6.55 | 4.835 | 3551582 | 5.48856334 | CS |
| 12 | 0.232 | 4.33685391158 | 5.3495 | 6.55 | 4.32 | 4244354 | 5.27684982 | CS |
| 26 | -0.0885 | -1.56084656085 | 5.67 | 7.18 | 4.32 | 4026231 | 5.47779101 | CS |
| 52 | -3.0785 | -35.5484988453 | 8.66 | 9.33 | 4.32 | 4371908 | 6.19888702 | CS |
| 156 | 4.6375 | 491.26059322 | 0.944 | 10.13 | 0.4902 | 5420833 | 4.26709574 | CS |
| 260 | -0.6685 | -10.696 | 6.25 | 10.13 | 0.4902 | 5000210 | 3.59763891 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
